Skip to content
MS
rate-limiting unreviewed

Serine palmitoyltransferase (SPT)

1 reactions · 1 pathways

Clinical / pharmacological. Rate-limiting for sphingolipid synthesis; SPTLC1 mutations cause HSAN type I

What it does, reaction by reaction

1 reactions

Sphingolipid Synthesis Lipid Metabolism · ER + Golgi

step 1 Irreversible rate-limiting

Serine + palmitoyl-CoA -> 3-ketosphinganine + CO2 + CoA-SH

Converts Serine Palmitoyl-CoA into 3-Ketosphinganine CO2 CoA-SH

Notes

Rate-limiting and committed step; located on the ER.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

0 entries

No regulation recorded for this enzyme in the source documents.

Recent literature

Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.

Europe PMC · ten most recent, newest first